Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection – Nature.com

by

  1. Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection Nature.com
  2. Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection | Proceedings of the National Academy of Sciences pnas.org
  3. ACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelae News-Medical.Net
  4. SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity Nature.com
  5. Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial The Lancet
  6. View Full Coverage on Google News

Read original article here

Leave a Comment